Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Keystone, EC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Keystone, EC
      Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    2. Furst, DE; Keystone, EC; Breedveld, FC; Kalden, JR; Smolen, JS; Antoni, CE; Burmester, GR; Crofford, LJ; Kavanaugh, A
      Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)

      ANNALS OF THE RHEUMATIC DISEASES
    3. Keystone, EC
      The role of tumor necrosis factor antagonism in clinical practice (vol 26,suppl 57, pg 22, 1999)

      JOURNAL OF RHEUMATOLOGY
    4. Bathon, JM; Martin, RW; Fleischmann, RM; Tesser, JR; Schiff, MH; Keystone, EC; Genovese, MC; Wasko, MC; Moreland, LW; Weaver, AL; Markenson, J; Finck, BK
      A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Furst, DE; Breedveld, FC; Burmester, GR; Crofford, JJ; Emery, P; Feldmann, M; Kalden, JR; Kavanaugh, AF; Keystone, EC; Klareskog, LG; Lipsky, PE; Maini, RN; Russell, AS; Scott, DL; Smolen, JS; Van de Putte, LBA; Visher, TL; Weisman, MH
      Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)

      ANNALS OF THE RHEUMATIC DISEASES
    6. Anderson, IF; Helve, T; Hannonen, P; Leirisalo-Repo, M; Gilboe, IM; Nissila, M; Keystone, EC; Kraag, GR; Bjorneboe, O; Chalmers, A; Dovland, H; Mueller, E; Richard, F; Whatmough, I; Schmidt, AG; Kovarik, JM
      Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: A double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics

      JOURNAL OF RHEUMATOLOGY
    7. Keesal, N; Wasserman, MJ; Bookman, A; Lapp, V; Weber, DA; Keystone, EC
      Thalidomide in the treatment of refractory rheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    8. Keystone, EC
      The role of tumor necrosis factor antagonism in clinical practice

      JOURNAL OF RHEUMATOLOGY
    9. Moreland, LW; Schiff, MH; Baumgartner, SW; Tindall, EA; Fleischmann, RM; Bulpitt, KJ; Weaver, AL; Keystone, EC; Furst, DE; Mease, PJ; Ruderman, EM; Horwitz, DA; Arkfeld, DG; Garrison, L; Burge, DJ; Blosch, CM; Lange, MLM; McDonnell, ND; Weinblatt, ME
      Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial

      ANNALS OF INTERNAL MEDICINE
    10. MORELAND IW; SCHIFF MH; BAUMGARTNER SW; TINDALL EA; FLEISCHMANN RM; BULPITT KJ; WEAVER A; KEYSTONE EC; WEINBLATT ME; FURST D; MEASE P; RUDERMAN E; ARKFELD DG; BLESCH CM
      PHASE-III TRIAL OF DMARD FAILING RHEUMATOID-ARTHRITIS PATIENTS WITH TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM))

      Journal of investigative medicine
    11. VANDENBOSH F; RUSSELL A; KEYSTONE EC; MORELAND LW; STCLAIR E; WEINBLATT M; LIPSKY P; BULPITT KJ; KUCHARSKI K; GRINT P; WHERRY JC
      RHUIL-4 IN SUBJECTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA) - A PHASE-1DOSE ESCALATING SAFETY STUDY

      Arthritis and rheumatism
    12. MORELAND LW; BAUMGARTNER SW; SCHIFF MH; TINDALL EA; FLEISCHMANN RM; WEAVER AL; BULPITT KJ; WEINBLATT ME; KEYSTONE EC; ETTINGER RE; FURST D; MEASE P; GRUBER BL; KATZ RS; SKOSEY JL; ARKFELD DG; LIES RB; LANGE M; BLOSCH CM; GARRISON L
      OPTIMAL DOSE OF TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM))

      Arthritis and rheumatism
    13. BAUMGARTNER SW; MORELAND LW; SCHIFF MH; TINDALL EA; FLEISCHMANN RM; BULPITT KJ; WEAVER AL; KEYSTONE EC; WEINBLATT ME; FURST D; MEASE P; RUDERMAN EM; ARKFELD DG; LANGE M; GARRISON L
      RESPONSE OF ELDERLY PATIENTS TO TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC, ENBREL(TM))

      Arthritis and rheumatism
    14. RATKAY LG; CHOWDHARY RK; IAMAROON A; RICHTER AM; NEYNDORFF HC; KEYSTONE EC; WATERFIELD JD; LEVY JG
      AMELIORATION OF ANTIGEN-INDUCED ARTHRITIS IN RABBITS BY INDUCTION OF APOPTOSIS OF INFLAMMATORY CELLS WITH LOCAL APPLICATION OF TRANSDERMAL PHOTODYNAMIC THERAPY

      Arthritis and rheumatism
    15. EDBERG JC; WAINSTEIN E; WU JM; CSERNOK E; SNELLER MC; HOFFMAN GS; KEYSTONE EC; GROSS WL; KIMBERLY RP
      ANALYSIS OF FC-GAMMA-RII GENE POLYMORPHISMS IN WEGENERS GRANULOMATOSIS

      Experimental and clinical immunogenetics
    16. LACAVA A; NELSON JL; OLLIER WER; MACGREGOR A; KEYSTONE EC; THORNE JC; SCAVULLI JF; BERRY CC; CARSON DA; ALBANI S
      GENETIC BIAS IN IMMUNE-RESPONSES TO A CASSETTE SHARED BY DIFFERENT MICROORGANISMS IN PATIENTS WITH RHEUMATOID-ARTHRITIS

      The Journal of clinical investigation
    17. WEINBLATT M; MORELAND LW; SCHIFF MH; BAUMGARTNER SW; TINDALL E; FLEISCHMANN RM; BULPITT KJ; WEAVER A; KEYSTONE EC; MEASE P; FURST D; RUDERMAN E; ARKFELD DG; ETTLINGER R; GRUBER BL; DUGAN A; BLOSCH CM
      LONG-TERM AND PHASE IN TREATMENT OF DMARD FAILING RHEUMATOID-ARTHRITIS PATIENTS WITH TNF RECEPTOR P75 FC FUSION PROTEIN (TNFR-FC ENBREL(TM))

      Arthritis and rheumatism
    18. SCOTT BB; WEISBROT LM; GREENWOOD JD; BOGOCH ER; PAIGE CJ; KEYSTONE EC
      RHEUMATOID-ARTHRITIS SYNOVIAL FIBROBLAST AND U937 MACROPHAGE MONOCYTECELL-LINE INTERACTION IN CARTILAGE DEGRADATION/

      Arthritis and rheumatism
    19. LIN MKS; FAREWELL V; VADAS P; BOOKMAN AAM; KEYSTONE EC; PRUZANSKI W
      SECRETORY PHOSPHOLIPASE A(2) AS AN INDEX OF DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS - PROSPECTIVE DOUBLE-BLIND-STUDY OF 212 PATIENTS

      Journal of rheumatology
    20. KEYSTONE EC; STRAND V
      BIOLOGIC AGENTS IN AUTOIMMUNE-DISEASES

      Journal of rheumatology
    21. BUCHT A; LARSSON P; WEISBROT L; THORNE C; PISA P; SMEDEGARD G; KEYSTONE EC; GRONBERG A
      EXPRESSION OF INTERFERON-GAMMA (IFN-GAMMA), IL-10, IL-12 AND TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) MESSENGER-RNA IN SYNOVIAL-FLUID CELLS FROM PATIENTS IN THE EARLY AND LATE PHASES OF RHEUMATOID-ARTHRITIS (RA)

      Clinical and experimental immunology
    22. ROBINSON E; KEYSTONE EC; SCHALL TJ; GILLETT N; FISH EN
      CHEMOKINE EXPRESSION IN RHEUMATOID-ARTHRITIS (RA) - EVIDENCE OF RANTES AND MACROPHAGE INFLAMMATORY PROTEIN (MIP)-1-BETA PRODUCTION BY SYNOVIAL T-CELLS

      Clinical and experimental immunology
    23. JOLLY SS; BROWNSTEIN S; JORDAN DR; MUNRO SM; KEYSTONE EC
      SCLERITIS IN A PATIENT WITH LIMITED WEGENERS GRANULOMATOSIS AND TAKAYASUS-ARTERITIS

      Canadian journal of ophthalmology
    24. SCOTT BB; WEISBROT LM; GREENWOOD JD; BOGOCH E; PAIGE CJ; KEYSTONE EC
      A HUMAN IN-VITRO MODEL OF SYNOVIAL FIBROBLASTS MACROPHAGE INTERACTIONIN CARTILAGE DESTRUCTION IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    25. MURTO SMH; WEBER DA; BADLEY EM; KEESAL NB; SMYTHE HA; KEYSTONE EC; LEWTAS J
      ELEVATED ANTICARDIOLIPIN LEVELS IN PATIENTS WITH LARGE VESSEL VASCULITIS

      Arthritis and rheumatism
    26. KEYSTONE EC; WEISBROT LM; WEBER DA; BLOSCH CM; BELL MJ; THORNE JC
      CYTOKINE AND SOLUBLE CYTOKINE RECEPTOR LEVELS IN RHEUMATOID-ARTHRITIS- A COMPARISON BETWEEN UNTREATED PATIENTS WITH EARLY AND LATE DISEASE

      Arthritis and rheumatism
    27. LACAVA A; NELSON JL; OLLIER WE; KEYSTONE EC; CARSON DA; ALBANI S
      THE QKRAA SUSCEPTIBILITY SEQUENCE TO RHEUMATOID-ARTHRITIS (RA) IS AN IMMUNOLOGICAL CASSETTE EXPRESSED BY MICROORGANISMS RELATED TO RA ETIOPATHOGENESIS

      Arthritis and rheumatism
    28. MURTO SMH; WEBER DA; LEWTAS J; BADLEY EM; KEESAL NB; SMYTHE HA; KEYSTONE EC
      ELEVATED ANTICARDIOLIPIN ANTIBODY-LEVELS IN PATIENTS WITH LARGE VESSEL VASCULITIS

      Arthritis and rheumatism
    29. MADER R; PAUZNER R; KEYSTONE EC; NICOL PD; SEHGAL VJ; TURLEY JJ
      SERUM MYOSIN LIGHT-CHAIN DETERMINATIONS IN PATIENTS WITH INFLAMMATORYMYOPATHY - A PRELIMINARY-REPORT

      Annals of the Rheumatic Diseases
    30. ABUSHAKRA M; KHRAISHI M; GROSMAN H; LEWTAS J; CIVIDINO A; KEYSTONE EC
      PRIMARY ANGIITIS OF THE CNS DIAGNOSED BY ANGIOGRAPHY

      Quarterly Journal of Medicine
    31. ATKINSON MJ; NARENDRAN A; PAIGE CJ; KEYSTONE EC
      IGA ANTIBODIES FROM RHEUMATOID-ARTHRITIS SYNOVIAL-FLUID BIND TO B-CELLS AND STIMULATE ANTIBODY-PRODUCTION

      The FASEB journal
    32. LEBLANC BAEW; KEYSTONE EC; FELTIS JT; GEDDIE WR; LIE JT
      POLYARTERITIS-NODOSA CLINICALLY MASQUERADING AS TEMPORAL ARTERITIS WITH LYMPHADENOPATHY

      Journal of rheumatology
    33. MADER R; NICOL PD; TURLEY JJ; BILBAO J; KEYSTONE EC
      INFLAMMATORY MYOPATHY - EARLY DIAGNOSIS AND MANAGEMENT BY SERUM MYOSIN LIGHT-CHAINS MEASUREMENTS

      Israel journal of medical sciences
    34. MADER R; NARENDRAN A; LEWTAS J; BYKERK V; GOODMAN RCJ; DICKSON JR; KEYSTONE EC
      SYSTEMIC VASCULITIS FOLLOWING INFLUENZA VACCINATION - REPORT OF 3 CASES AND LITERATURE-REVIEW

      Journal of rheumatology
    35. MADER R; KEYSTONE EC
      INFLAMMATORY MYOPATHY - DO WE HAVE ADEQUATE MEASURES OF THE TREATMENTRESPONSE

      Journal of rheumatology
    36. KREIDSTEIN SH; LYTWYN A; KEYSTONE EC
      TAKAYASU ARTERITIS WITH ACUTE INTERSTITIAL PNEUMONIA AND CORONARY VASCULITIS - EXPANDING THE SPECTRUM

      Arthritis and rheumatism
    37. CHEN E; KEYSTONE EC; FISH EN
      RESTRICTED CYTOKINE EXPRESSION IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    38. DAGENAIS P; DALPE G; LUCENAFERNANDES F; BOIRE G; KEYSTONE EC; MENARD HA
      SPECIFIC ANTIBODIES AGAINST SERINE PROTEINASE-3 MYELOBLASTIN (WEGENERS AUTOANTIGEN) FOUND IN A PATIENT WITH A TAKAYASU ARTERITIS

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:14:15